{"id":17541,"date":"2026-02-24T17:55:23","date_gmt":"2026-02-24T17:55:23","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/17541\/"},"modified":"2026-02-24T17:55:23","modified_gmt":"2026-02-24T17:55:23","slug":"pharma-company-roche-approaches-supreme-court-against-delhi-high-court-allowing-natco-to-make-generic-drug-for-spinal-muscular-atrophy","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/17541\/","title":{"rendered":"Pharma Company Roche Approaches Supreme Court Against Delhi High Court Allowing Natco To Make Generic Drug For Spinal Muscular Atrophy"},"content":{"rendered":"<p>Swiss pharmaceutical giant F Hoffmann-La Roche AG has approached the Supreme Court against the Delhi High Court&#8217;s order allowing Natco Pharma to manufacture and sell a generic drug of Risdiplam, a drug used to treat Spinal Muscular Atrophy (SMA).The counsel for Roche mentioned the matter before Chief Justice of India for urgent listing. CJI agreed to list the matter.On October 9, a division&#8230;<\/p>\n","protected":false},"excerpt":{"rendered":"Swiss pharmaceutical giant F Hoffmann-La Roche AG has approached the Supreme Court against the Delhi High Court&#8217;s order&hellip;\n","protected":false},"author":2,"featured_media":17542,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[9805,134,2147],"class_list":["post-17541","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-natco-pharma","tag-roche","tag-supreme-court"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/17541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=17541"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/17541\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/17542"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=17541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=17541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=17541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}